Delivery Order SPE2DB22D3501-SPE2DB25FXC65
- Not listed
- The Defense Logistics Agency awarded a $10,974.69 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is...
- The Defense Logistics Agency awarded a $2,789.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, a psychiatric medication. This award was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical distributor will perform the work at its corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 100 mg tablets (60-count) under a firm fixed-price contract with a ceiling value of $11,044.73. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,316.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Briviact 100 mg, a medication used in the treatment of psychiatric conditions. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery order under a larger pharmaceutical supply agreement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,138.04 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Briviact 75 mg tablets (60 count) with a contract value of $7,826.28. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract has an ultimate completion date of August 28, 2025, and performance will take place at the awardee's corporate...
- The Defense Logistics Agency awarded a $7,234.61 delivery order to AmerisourceBergen Drug Corp for Briviact 10 mg/ml oral solution (300ml) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $8,376.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Briviact 25 mg tablets (60-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract is unclassified as a set-aside and represents a small-value transaction typical of the company's extensive pharmaceutical supply work with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXC65Delivery Order
The Defense Logistics Agency awarded a $8,509.97 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Briviact 100 mg, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. This delivery order for Briviact—a psychiatric medication used in the treatment of schizophrenia—supports the pharmaceutical supply needs of the military health system through AmerisourceBergen's established prime vendor relationship with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 9/2/25 |